Hurdles and complexities of codon 13 KRAS mutations

J Clin Oncol. 2012 Oct 10;30(29):3565-7. doi: 10.1200/JCO.2012.43.6535. Epub 2012 Aug 27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cetuximab
  • Codon
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Evidence-Based Medicine
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Mutation
  • Needs Assessment
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins p21(ras)
  • Retrospective Studies
  • Sensitivity and Specificity
  • ras Proteins / genetics*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Codon
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
  • Cetuximab